Correction equation for ECG time intervals.
作者信息
Kelman A W, Whiting B, Summer D J
出版信息
Br J Clin Pharmacol. 1984 Jul;18(1):113-5. doi: 10.1111/j.1365-2125.1984.tb05036.x.
Abstract
摘要
相似文献
1
Correction equation for ECG time intervals.
Br J Clin Pharmacol. 1984 Jul;18(1):113-5. doi: 10.1111/j.1365-2125.1984.tb05036.x.
2
A simple method for ECG and VCG assessment of the severity of pulmonary valve stenosis.
Eur J Cardiol. 1977 Aug;5(6):453-62.
3
Real-time PC-based system for dynamic beat-to-beat QT-RR analysis.
Comput Biomed Res. 1999 Aug;32(4):336-54. doi: 10.1006/cbmr.1999.1514.
4
Evaluation of the electrocardiographic signs of left ventricular hypertrophy, using the echocardiography in patients with hypertensive cardiopathy.
Rom J Intern Med. 1992 Jul-Sep;30(3):187-92.
5
Gender-specific comparison of five QT correction formulae in middle-aged participants in an atherosclerosis prevention program.
Med Sci Monit. 2007 Apr;13(4):CR165-71.
6
A meta-analysis of ECG data from healthy male volunteers: diurnal and intra-subject variability, and implications for planning ECG assessments and statistical analysis in clinical pharmacology studies.
Eur J Clin Pharmacol. 2006 Nov;62(11):893-903. doi: 10.1007/s00228-006-0194-z. Epub 2006 Oct 6.
7
Surveillance for postoperative myocardial infarction after noncardiac operations.
Surg Gynecol Obstet. 1988 Nov;167(5):407-14.
8
Subject identification via ECG fiducial-based systems: influence of the type of QT interval correction.
Comput Methods Programs Biomed. 2015 Oct;121(3):127-36. doi: 10.1016/j.cmpb.2015.05.012. Epub 2015 Jun 25.
9
[Measurements of characteristics of Holter ECG and its evaluation for ST segment analysis].
Iyodenshi To Seitai Kogaku. 1985 Jun;23(3):188-93.
10
Methodology of ECG interpretation in the Louvain program.
Methods Inf Med. 1990 Sep;29(4):403-9.
引用本文的文献
1
Indoramin-prolongation of repolarization time, a mechanism of bradycardia in man?
Br J Clin Pharmacol. 1985 Feb;19(2):266-71. doi: 10.1111/j.1365-2125.1985.tb02642.x.
2
Uncorrected pre-ejection period: a simple non-invasive measurement for pharmacodynamic screening of inotropic activity.
Eur J Clin Pharmacol. 1987;31(5):559-62. doi: 10.1007/BF00606630.
3
Relation of human cardiac action potential duration to the interval between beats: implications for the validity of rate corrected QT interval (QTc).
Br Heart J. 1987 Jan;57(1):32-7. doi: 10.1136/hrt.57.1.32.
4
The effects of the 5 HT2 antagonist ritanserin on blood pressure and serotonin-induced platelet aggregation in patients with untreated essential hypertension.
Eur J Clin Pharmacol. 1988;35(2):123-9. doi: 10.1007/BF00609240.
本文引用的文献
1
The prediction of individual systolic time interval v heart rate regression equations.
Br J Clin Pharmacol. 1981 Jul;12(1):21-30. doi: 10.1111/j.1365-2125.1981.tb01850.x.
2
Systolic time interval v heart rate regression equations using atropine: reproducibility studies.
Br J Clin Pharmacol. 1981 Jul;12(1):15-20. doi: 10.1111/j.1365-2125.1981.tb01849.x.
3
The QT interval and cycle length: the influence of atropine, hyoscine and exercise.
Br J Clin Pharmacol. 1983 Dec;16(6):615-21. doi: 10.1111/j.1365-2125.1983.tb02230.x.
4
Systolic time intervals in heart failure in man.
Circulation. 1968 Feb;37(2):149-59. doi: 10.1161/01.cir.37.2.149.
5
Relationship between the pharmacokinetics and pharmacodynamics of procainamide.
Clin Pharmacol Ther. 1976 Sep;20(3):278-89. doi: 10.1002/cpt1976203278.
6
Measurement of systolic time intervals.
Br J Clin Pharmacol. 1978 Dec;6(6):549-50. doi: 10.1111/j.1365-2125.1978.tb00886.x.
Zotero 插件